Silk Nanoparticle Synthesis: Tuning Size, Dispersity, and Surface Chemistry for Drug Delivery
Source abstract
Abstract
Protein-based nanoparticles have gained interest for traversing different biological (e.g., systemic or microenvironmental, etc.) barriers and enabling targeted drug delivery. Silk protein-based nanoparticles are useful and versatile drug delivery systems for sustained and controlled release due to their biocompatibility, biodegradability, accessible chemistries, and ability to stabilize different drugs and other biomolecules. In the present study, silk nanoparticles (SNPs) were engineered using a nanoprecipitation technique with tight control over size (∼45–250 nm diameter) and low polydispersity index by altering variables including stirring speed, reaction bath temperature, silk molecular weight (MW), and silk concentration. Of these variables, stir speed was the most significant contributor toward particle size control. SNPs with positive or negative surface charges and decoration of SNPs with surface antigens were also demonstrated. New mechanistic insights into control of SNP size, cellular uptake using glioblastoma as a model, surface characteristics, and the entrapment of a small-molecule drug (doxorubicin) within the particles were addressed. These insights expand the potential utility of SNPs for medical, environmental, and food applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Silk-based biomaterials and applications · Polymer Surface Interaction Studies · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States
Department of Chemistry and Biochemistry, San Diego State University, San Diego, California 92182-1030, United States
Funding
Air Force Office of Scientific Research · National Institute of Biomedical Imaging and Bioengineering
References (62)
Show source-provided references
1. 10.1002/btm2.1014310.1002/btm2.10143 ↗
2. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
3. 10.3390/antibiotics702004610.3390/antibiotics7020046 ↗
4. 10.1186/s12951-019-0567-y10.1186/s12951-019-0567-y ↗
5. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
6. 10.1002/jps.260073093410.1002/jps.2600730934 ↗
7. 10.1111/j.2042-7158.1990.tb07033.x10.1111/j.2042-7158.1990.tb07033.x ↗
8. 10.3389/fphar.2021.60162610.3389/fphar.2021.601626 ↗
9. 10.1038/s41598-020-64464-910.1038/s41598-020-64464-9 ↗
10. 10.1038/s41598-020-80708-010.1038/s41598-020-80708-0 ↗
11. 10.1002/advs.20210401210.1002/advs.202104012 ↗
12. 10.1021/acs.biomac.0c0009010.1021/acs.biomac.0c00090 ↗
13. 10.3390/nano1004065610.3390/nano10040656 ↗
14. 10.1371/journal.pone.013142910.1371/journal.pone.0131429 ↗
15. 10.1016/j.addr.2013.12.00910.1016/j.addr.2013.12.009 ↗
16. 10.1002/btm2.1015310.1002/btm2.10153 ↗
17. 10.1016/j.jconrel.2022.03.04310.1016/j.jconrel.2022.03.043 ↗
18. 10.3791/5466910.3791/54669 ↗
19. 10.1016/j.jconrel.2022.02.01110.1016/j.jconrel.2022.02.011 ↗
20. 10.1016/j.biomaterials.2009.11.00210.1016/j.biomaterials.2009.11.002 ↗
21. 10.1038/srep1187810.1038/srep11878 ↗
22. 10.1021/acsbiomaterials.6b0045710.1021/acsbiomaterials.6b00457 ↗
23. 10.1021/acsbiomaterials.0c0020210.1021/acsbiomaterials.0c00202 ↗
24. 10.4103/1735-5362.19904110.4103/1735-5362.199041 ↗
25. 10.1080/21691401.2016.127692410.1080/21691401.2016.1276924 ↗
26. 10.3390/pharmaceutics1310153710.3390/pharmaceutics13101537 ↗
27. 10.1080/09205063.2018.145602710.1080/09205063.2018.1456027 ↗
28. 10.1039/C6RA06563E10.1039/C6RA06563E ↗
29. 10.1016/j.ijpharm.2020.11915010.1016/j.ijpharm.2020.119150 ↗
30. 10.1002/adhm.20130003410.1002/adhm.201300034 ↗
31. 10.1021/acsbiomaterials.0c0102810.1021/acsbiomaterials.0c01028 ↗
32. 10.1002/mabi.20120032310.1002/mabi.201200323 ↗
33. Daeihamed M. · Iran J. Pharm. Res. · 2015 · 14 · 3310.18579/jpcrkc/2015/14/2/79075 ↗
34. 10.1021/acs.biomac.0c0052310.1021/acs.biomac.0c00523 ↗
35. 10.1016/j.actbio.2011.03.00110.1016/j.actbio.2011.03.001 ↗
36. 10.1016/j.biomaterials.2007.11.00310.1016/j.biomaterials.2007.11.003 ↗
37. 10.1016/j.ijbiomac.2018.07.01710.1016/j.ijbiomac.2018.07.017 ↗
38. 10.1021/bm200062a10.1021/bm200062a ↗
39. 10.3390/molecules2707236810.3390/molecules27072368 ↗
40. 10.1021/acsbiomaterials.0c0102810.1021/acsbiomaterials.0c01028 ↗
41. 10.3390/nano909132910.3390/nano9091329 ↗
42. 10.1021/acsami.0c1234110.1021/acsami.0c12341 ↗
43. 10.1002/cbic.20220042910.1002/cbic.202200429 ↗
44. 10.1016/j.nantod.2015.07.00210.1016/j.nantod.2015.07.002 ↗
45. 10.1039/C8NA00208H10.1039/C8NA00208H ↗
46. 10.1002/cssc.20080003010.1002/cssc.200800030 ↗
47. 10.1002/jbm.a.3651610.1002/jbm.a.36516 ↗
48. 10.1073/pnas.060861110410.1073/pnas.0608611104 ↗
49. 10.3389/fphar.2019.0119610.3389/fphar.2019.01196 ↗
50. Sandri G. · 2014 · 32310.1007/978-3-319-00714-4_11 ↗
51. 10.3390/ma1321494610.3390/ma13214946 ↗
52. 10.1016/j.nantod.2014.04.00810.1016/j.nantod.2014.04.008 ↗
53. 10.1007/s11095-021-03015-x10.1007/s11095-021-03015-x ↗
54. 10.1038/s41565-020-0639-z10.1038/s41565-020-0639-z ↗
55. 10.2478/jtim-2018-002510.2478/jtim-2018-0025 ↗
56. 10.1016/j.addr.2011.12.00610.1016/j.addr.2011.12.006 ↗
57. 10.1038/s41556-022-00962-410.1038/s41556-022-00962-4 ↗
58. 10.1593/neo.1068810.1593/neo.10688 ↗
59. 10.3389/fonc.2019.0084910.3389/fonc.2019.00849 ↗
60. 10.1039/C7RA03208K10.1039/C7RA03208K ↗
61. 10.1016/j.canlet.2014.07.01810.1016/j.canlet.2014.07.018 ↗
62. 10.3390/jcm803033110.3390/jcm8030331 ↗